Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model

We and others have shown in various in vivo, ex vivo and cell culture models that several tau antibodies interact with pathological tau within neurons. To further clarify this interaction in a dynamic human model, we differentiated SH-SY5Y cells with retinoic acid and BDNF to create a neuron-like mo...

Full description

Bibliographic Details
Main Authors: Dov B. Shamir, Yan Deng, Qian Wu, Swananda Modak, Erin E. Congdon, Einar M. Sigurdsson
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.602292/full
_version_ 1818728586042933248
author Dov B. Shamir
Yan Deng
Qian Wu
Swananda Modak
Erin E. Congdon
Einar M. Sigurdsson
Einar M. Sigurdsson
author_facet Dov B. Shamir
Yan Deng
Qian Wu
Swananda Modak
Erin E. Congdon
Einar M. Sigurdsson
Einar M. Sigurdsson
author_sort Dov B. Shamir
collection DOAJ
description We and others have shown in various in vivo, ex vivo and cell culture models that several tau antibodies interact with pathological tau within neurons. To further clarify this interaction in a dynamic human model, we differentiated SH-SY5Y cells with retinoic acid and BDNF to create a neuron-like model. Therein, tau antibodies were primarily taken up by receptor-mediated endocytosis, and prevented toxicity of human brain-derived paired helical filament-enriched tau (PHF). Subsequently, we monitored in real-time the interaction of antibodies and PHF within endocytic cellular compartments. Cells were pre-treated with fluorescently-tagged PHF and then incubated with tau antibodies, 4E6, 6B2, or non-specific isotype control IgG1 labeled with a pH sensitive dye. The uptake and binding of the efficacious antibody, 4E6, to PHF occurred mainly within the soma, whereas the ineffective antibody, 6B2, and ineffective control IgG1, were visualized via the processes and showed limited colocalization with PHF within this period. In summary, we have developed a neuron-like model that clarifies the early intracellular dynamics of the interaction of tau antibodies with pathological tau, and identifies features associated with efficacy. Since the model is entirely human, it is suitable to verify the therapeutic potential of humanized antibodies prior to extensive clinical trials.
first_indexed 2024-12-17T22:32:21Z
format Article
id doaj.art-0f74233ab16b469c9209c49f60069447
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-17T22:32:21Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-0f74233ab16b469c9209c49f600694472022-12-21T21:30:09ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-11-011110.3389/fneur.2020.602292602292Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like ModelDov B. Shamir0Yan Deng1Qian Wu2Swananda Modak3Erin E. Congdon4Einar M. Sigurdsson5Einar M. Sigurdsson6Department of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United StatesMicroscopy Core, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY, United StatesWe and others have shown in various in vivo, ex vivo and cell culture models that several tau antibodies interact with pathological tau within neurons. To further clarify this interaction in a dynamic human model, we differentiated SH-SY5Y cells with retinoic acid and BDNF to create a neuron-like model. Therein, tau antibodies were primarily taken up by receptor-mediated endocytosis, and prevented toxicity of human brain-derived paired helical filament-enriched tau (PHF). Subsequently, we monitored in real-time the interaction of antibodies and PHF within endocytic cellular compartments. Cells were pre-treated with fluorescently-tagged PHF and then incubated with tau antibodies, 4E6, 6B2, or non-specific isotype control IgG1 labeled with a pH sensitive dye. The uptake and binding of the efficacious antibody, 4E6, to PHF occurred mainly within the soma, whereas the ineffective antibody, 6B2, and ineffective control IgG1, were visualized via the processes and showed limited colocalization with PHF within this period. In summary, we have developed a neuron-like model that clarifies the early intracellular dynamics of the interaction of tau antibodies with pathological tau, and identifies features associated with efficacy. Since the model is entirely human, it is suitable to verify the therapeutic potential of humanized antibodies prior to extensive clinical trials.https://www.frontiersin.org/articles/10.3389/fneur.2020.602292/fullAlzheimer's diseasetauPHFantibodiesimmunotherapieslive imaging
spellingShingle Dov B. Shamir
Yan Deng
Qian Wu
Swananda Modak
Erin E. Congdon
Einar M. Sigurdsson
Einar M. Sigurdsson
Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
Frontiers in Neurology
Alzheimer's disease
tau
PHF
antibodies
immunotherapies
live imaging
title Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
title_full Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
title_fullStr Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
title_full_unstemmed Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
title_short Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
title_sort dynamics of internalization and intracellular interaction of tau antibodies and human pathological tau protein in a human neuron like model
topic Alzheimer's disease
tau
PHF
antibodies
immunotherapies
live imaging
url https://www.frontiersin.org/articles/10.3389/fneur.2020.602292/full
work_keys_str_mv AT dovbshamir dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT yandeng dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT qianwu dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT swanandamodak dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT erinecongdon dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT einarmsigurdsson dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel
AT einarmsigurdsson dynamicsofinternalizationandintracellularinteractionoftauantibodiesandhumanpathologicaltauproteininahumanneuronlikemodel